{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:21:34Z","timestamp":1792801294352,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770359"],"award-info":[{"award-number":["81770359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270276"],"award-info":[{"award-number":["81270276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500365"],"award-info":[{"award-number":["81500365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project Fund of State Key Laboratory of Molecular Developmental Biology of China","award":["2021-MDB-KF-18"],"award-info":[{"award-number":["2021-MDB-KF-18"]}],"id":[{"id":"https:\/\/ror.org\/04caj7738","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Open Project Fund of State Key Laboratory of Molecular Developmental Biology of China","award":["2020-MDB-KF-17"],"award-info":[{"award-number":["2020-MDB-KF-17"]}],"id":[{"id":"https:\/\/ror.org\/04caj7738","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Health Technologies Promotion Program","award":["BHTPP202004"],"award-info":[{"award-number":["BHTPP202004"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7172040"],"award-info":[{"award-number":["7172040"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerotic plaque vulnerability is a key feature of atheroprogression and precipitating acute cardiovascular events. Although the pivotal role of epigenetic regulation in atherosclerotic plaque destabilization is being recognized, the DNA methylation profile and its potential role in driving the progression and destabilization of atherosclerotic cardiovascular disease remains largely unknown. We conducted a genome-wide analysis to identify differentially methylated genes in vulnerable and non-vulnerable atherosclerotic lesions to understand more about pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We compared genome-wide DNA methylation profiling between carotid artery plaques of patients with clinically symptomatic (recent stroke or transient ischemic attack) and asymptomatic disease (no recent stroke) using Infinium Methylation BeadChip arrays, which revealed 90,368 differentially methylated sites (FDR\u2009&lt;\u20090.05, |delta beta|&gt;\u20090.03) corresponding to 14,657 annotated genes. Among these genomic sites, 30% were located at the promoter regions and 14% in the CpG islands, according to genomic loci and genomic proximity to the CpG islands, respectively. Moreover, 67% displayed hypomethylation in symptomatic plaques, and the differentially hypomethylated genes were found to be involved in various aspects of inflammation. Subsequently, we focus on CpG islands and revealed 14,596 differentially methylated sites (|delta beta|&gt;\u20090.1) located at the promoter regions of 7048 genes. Integrated analysis of methylation and gene expression profiles identified that 107 genes were hypomethylated in symptomatic plaques and showed elevated expression levels in both advanced plaques and ruptured plaques. The imprinted gene\n                      <jats:italic>PLA2G7<\/jats:italic>\n                      , which encodes lipoprotein-associated phospholipase A\n                      <jats:sub>2<\/jats:sub>\n                      (Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      ), was one of the top hypomethylated genes with an increased expression upon inflammation. Further, the hypomethylated CpG site at the promoter region of\n                      <jats:italic>PLA2G7<\/jats:italic>\n                      was identified as cg11874627, demethylation of which led to increased binding of Sp3 and expression of Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      through bisulfate sequencing, chromatin immunoprecipitation assay and enzyme-linked immunosorbent assay. These effects were further enhanced by deacetylase.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Extensive DNA methylation modifications serve as a new and critical layer of biological regulation that contributes to atheroprogression and destabilization via inflammatory processes. Revelation of this hitherto unknown epigenetic regulatory mechanism could rejuvenate the prospects of Lp-PLA\n                      <jats:sub>2<\/jats:sub>\n                      as a therapeutic target to stabilize the atherosclerotic plaque and reduce clinical sequelae.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-021-01152-z","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T05:03:05Z","timestamp":1629522185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque"],"prefix":"10.1186","volume":"13","author":[{"given":"Jingjin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zening","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-4713","authenticated-orcid":false,"given":"Jingyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"issue":"8","key":"1152_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"1","key":"1152_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1152_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/ATVBAHA.118.312135","volume":"39","author":"FM Davis","year":"2019","unstructured":"Davis FM, Gallagher KA. Epigenetic mechanisms in monocytes\/macrophages regulate inflammation in cardiometabolic and vascular disease. Arterioscler Thromb Vasc Biol. 2019;39(4):623\u201334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1152_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/epi.13.83","volume":"6","author":"AV Majnik","year":"2014","unstructured":"Majnik AV, Lane RH. Epigenetics: where environment, society and genetics meet. Epigenomics. 2014;6(1):1\u20134.","journal-title":"Epigenomics"},{"issue":"9","key":"1152_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng.2714","volume":"45","author":"CM Buchovecky","year":"2013","unstructured":"Buchovecky CM, Turley SD, Brown HM, Kyle SM, McDonald JG, Liu B, et al. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat Genet. 2013;45(9):1013\u201320.","journal-title":"Nat Genet"},{"issue":"6","key":"1152_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ajhg.2017.09.028","volume":"101","author":"MA Richard","year":"2017","unstructured":"Richard MA, Huan T, Ligthart S, Gondalia R, Jhun MA, Brody JA, et al. DNA methylation analysis identifies loci for blood pressure regulation. Am J Hum Genet. 2017;101(6):888\u2013902.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1152_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCGENETICS.116.001506","volume":"9","author":"R Joehanes","year":"2016","unstructured":"Joehanes R, Just AC, Marioni RE, Pilling LC, Reynolds LM, Mandaviya PR, et al. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet. 2016;9(5):436\u201347.","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"1152_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13148-020-00846-0","volume":"12","author":"JY Kim","year":"2020","unstructured":"Kim JY, Choi BG, Jelinek J, Kim DH, Lee SH, Cho K, et al. Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis. Clin Epigenetics. 2020;12(1):66.","journal-title":"Clin Epigenetics"},{"issue":"10","key":"1152_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2019.07.043","volume":"74","author":"B Rizzacasa","year":"2019","unstructured":"Rizzacasa B, Amati F, Romeo F, Novelli G, Mehta JL. Epigenetic modification in coronary atherosclerosis: JACC review topic of the week. J Am Coll Cardiol. 2019;74(10):1352\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1152_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg MVC, Bourc\u2019his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590\u2013607.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"1152_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.111.046755","volume":"125","author":"Y Doring","year":"2012","unstructured":"Doring Y, Manthey HD, Drechsler M, Lievens D, Megens RT, Soehnlein O, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation. 2012;125(13):1673\u201383.","journal-title":"Circulation"},{"issue":"1","key":"1152_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2012.09.037","volume":"226","author":"K Lee","year":"2013","unstructured":"Lee K, Santibanez-Koref M, Polvikoski T, Birchall D, Mendelow AD, Keavney B. Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture. Atherosclerosis. 2013;226(1):74\u201381.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1152_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","volume":"25","author":"A Zalewski","year":"2005","unstructured":"Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol. 2005;25(5):923\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1152_CR14","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1161\/01.ATV.19.12.2909","volume":"19","author":"T Hakkinen","year":"1999","unstructured":"Hakkinen T, Luoma JS, Hiltunen MO, Macphee CH, Milliner KJ, Patel L, et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1999;19(12):2909\u201317.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Pt 2","key":"1152_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/bj20030636","volume":"375","author":"X Wu","year":"2003","unstructured":"Wu X, McIntyre TM, Zimmerman GA, Prescott SM, Stafforini DM. Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages. Biochem J. 2003;375(Pt 2):351\u201363.","journal-title":"Biochem J"},{"issue":"10","key":"1152_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057\u201368.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"1152_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121\u201330.","journal-title":"Nat Genet"},{"key":"1152_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2018.12.006","volume":"281","author":"E Aavik","year":"2019","unstructured":"Aavik E, Babu M, Yl\u00e4-Herttuala S. DNA methylation processes in atheosclerotic plaque. Atherosclerosis. 2019;281:168\u201379.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1152_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0021-9150(02)00187-9","volume":"165","author":"MO Hiltunen","year":"2002","unstructured":"Hiltunen MO, Tuomisto TT, Niemi M, Br\u00e4sen JH, Rissanen TT, T\u00f6r\u00f6nen P, et al. Changes in gene expression in atherosclerotic plaques analyzed using DNA array. Atherosclerosis. 2002;165(1):23\u201332.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1152_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","volume":"17","author":"T Kuznetsova","year":"2020","unstructured":"Kuznetsova T, Prange KHM, Glass CK, de Winther MPJ. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat Rev Cardiol. 2020;17(4):216\u201328.","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"1152_CR21","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/ATVBAHA.119.312765","volume":"39","author":"JL Harman","year":"2019","unstructured":"Harman JL, Dobnikar L, Chappell J, Stokell BG, Dalby A, Foote K, et al. Epigenetic regulation of vascular smooth muscle cells by histone H3 lysine 9 dimethylation attenuates target gene-induction by inflammatory signaling. Arterioscler Thromb Vasc Biol. 2019;39(11):2289\u2013302.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1152_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, Luscher TF, Bonow RO, Verma S, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113\u201331.","journal-title":"Eur Heart J."},{"issue":"4","key":"1152_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/cvr\/cvw186","volume":"111","author":"C Tay","year":"2016","unstructured":"Tay C, Liu YH, Hosseini H, Kanellakis P, Cao A, Peter K, et al. B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation. Cardiovasc Res. 2016;111(4):385\u201397.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1152_CR24","first-page":"691","volume":"26","author":"SA Castillo-D\u00edaz","year":"2010","unstructured":"Castillo-D\u00edaz SA, Garay-Sevilla ME, Hern\u00e1ndez-Gonz\u00e1lez MA, Sol\u00eds-Mart\u00ednez MO, Zaina S. Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries. Int J Mol Med. 2010;26(5):691\u2013700.","journal-title":"Int J Mol Med"},{"issue":"22","key":"1152_CR25","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1093\/eurheartj\/ehp302","volume":"30","author":"W Koenig","year":"2009","unstructured":"Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J. 2009;30(22):2742\u20138.","journal-title":"Eur Heart J"},{"issue":"14","key":"1152_CR26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.105.612630","volume":"113","author":"M O'Donoghue","year":"2006","unstructured":"O\u2019Donoghue M, Morrow DA, Sabatine MS, Murphy SA, McCabe CH, Cannon CP, et al. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113(14):1745\u201352.","journal-title":"Circulation"},{"issue":"23","key":"1152_CR27","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1093\/eurheartj\/ehp309","volume":"30","author":"J Herrmann","year":"2009","unstructured":"Herrmann J, Mannheim D, Wohlert C, Versari D, Meyer FB, McConnell JP, et al. Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome. Eur Heart J. 2009;30(23):2930\u20138.","journal-title":"Eur Heart J"},{"issue":"10","key":"1152_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/nm.1870","volume":"14","author":"RL Wilensky","year":"2008","unstructured":"Wilensky RL, Shi Y, Mohler ER 3rd, Hamamdzic D, Burgert ME, Li J, et al. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med. 2008;14(10):1059\u201366.","journal-title":"Nat Med"},{"issue":"1","key":"1152_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/med.21597","volume":"40","author":"F Huang","year":"2020","unstructured":"Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: the story continues. Med Res Rev. 2020;40(1):79\u2013134.","journal-title":"Med Res Rev"},{"issue":"4","key":"1152_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41375-018-0293-8","volume":"33","author":"N Blagitko-Dorfs","year":"2019","unstructured":"Blagitko-Dorfs N, Schlosser P, Greve G, Pfeifer D, Meier R, Baude A, et al. Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation. Leukemia. 2019;33(4):945\u201356.","journal-title":"Leukemia"},{"issue":"10","key":"1152_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jama.2014.11061","volume":"312","author":"ML O'Donoghue","year":"2014","unstructured":"O\u2019Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014;312(10):1006\u201315.","journal-title":"JAMA"},{"issue":"8","key":"1152_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752\u201362.","journal-title":"N Engl J Med"},{"issue":"12","key":"1152_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"26","key":"1152_CR34","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"key":"1152_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2018.10.006","volume":"281","author":"I Nicorescu","year":"2019","unstructured":"Nicorescu I, Dallinga GM, de Winther MPJ, Stroes ESG, Bahjat M. Potential epigenetic therapeutics for atherosclerosis treatment. Atherosclerosis. 2019;281:189\u201397.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1152_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones PA, Ohtani H, Chakravarthy A, De Carvalho DD. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19(3):151\u201361.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1152_CR37","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1210\/en.2014-1595","volume":"155","author":"Q Cao","year":"2014","unstructured":"Cao Q, Wang X, Jia L, Mondal AK, Diallo A, Hawkins GA, et al. Inhibiting DNA methylation by 5-aza-2\u2019-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014;155(12):4925\u201338.","journal-title":"Endocrinology"},{"issue":"2","key":"1152_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"6327","key":"1152_CR39","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u20137.","journal-title":"Science"},{"issue":"1","key":"1152_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu XS, Wu H, Ji X, Stelzer Y, Wu X, Czauderna S, et al. Editing DNA methylation in the mammalian genome. Cell. 2016;167(1):233\u201347.","journal-title":"Cell"},{"issue":"16","key":"1152_CR41","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/eurheartj\/ehu437","volume":"36","author":"E Aavik","year":"2015","unstructured":"Aavik E, Lumivuori H, Lepp\u00e4nen O, Wirth T, H\u00e4kkinen SK, Br\u00e4sen JH, et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. Eur Heart J. 2015;36(16):993\u20131000.","journal-title":"Eur Heart J"},{"issue":"2","key":"1152_CR42","first-page":"390","volume":"114","author":"A Grei\u00dfel","year":"2015","unstructured":"Grei\u00dfel A, Culmes M, Napieralski R, Wagner E, Gebhard H, Schmitt M, et al. Alternation of histone and DNA methylation in human atherosclerotic carotid plaques. Thromb Haemost. 2015;114(2):390\u2013402.","journal-title":"Thromb Haemost"},{"issue":"10","key":"1152_CR43","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"DM Fernandez","year":"2019","unstructured":"Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019;25(10):1576\u201388.","journal-title":"Nat Med"},{"issue":"9746","key":"1152_CR44","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0140-6736(10)61197-X","volume":"376","author":"A Halliday","year":"2010","unstructured":"Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet. 2010;376(9746):1074\u201384.","journal-title":"Lancet"},{"issue":"5","key":"1152_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/bioinformatics\/bts013","volume":"28","author":"D Wang","year":"2012","unstructured":"Wang D, Yan L, Hu Q, Sucheston LE, Higgins MJ, Ambrosone CB, et al. IMA: an R package for high-throughput analysis of Illumina\u2019s 450K Infinium methylation data. Bioinformatics. 2012;28(5):729\u201330.","journal-title":"Bioinformatics"},{"issue":"4","key":"1152_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558\u201360.","journal-title":"Bioinformatics"},{"issue":"6","key":"1152_CR47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"9","key":"1152_CR48","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1101\/gr.092759.109","volume":"19","author":"M Krzywinski","year":"2009","unstructured":"Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19(9):1639\u201345.","journal-title":"Genome Res"},{"issue":"9","key":"1152_CR49","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1152_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinform. 2011;12:35.","journal-title":"BMC Bioinform"},{"issue":"86","key":"1152_CR51","first-page":"2579","volume":"9","author":"LVD Maaten","year":"2008","unstructured":"Maaten LVD, Hinton G. Visualizing data using t-SNE. J Mach Learn Res. 2008;9(86):2579\u2013605.","journal-title":"J Mach Learn Res."},{"issue":"Database issue","key":"1152_CR52","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkt997","volume":"42","author":"A Mathelier","year":"2014","unstructured":"Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 2014;42(Database issue):D142\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1152_CR53","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.89.5.1827","volume":"89","author":"M Frommer","year":"1992","unstructured":"Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89(5):1827\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1152_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jcb.24994","volume":"116","author":"W Liu","year":"2015","unstructured":"Liu W, Li J, Liu M, Zhang H, Wang N. PPAR-gamma promotes endothelial cell migration by inducing the expression of Sema3g. J Cell Biochem. 2015;116(4):514\u201323.","journal-title":"J Cell Biochem"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-021-01152-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-021-01152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T16:04:24Z","timestamp":1675613064000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-021-01152-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1186\/s13148-021-01152-z","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving humans were approved by the Institutional Ethics Review Board of China-Japan Friendship Hospital (No. 2019-85-K56) and conformed to the standards of the Declaration of Helsinki. All participants provided written informed consent before enrollment in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest relevant to the present manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}